Barry Callebaut Gets Cocoa Health Claim
A European health claim supports cocoa flavanols for their contribution to healthy blood flow.
Barry Callebaut (Zurich, Switzerland) has earned a cocoa health claim in Europe for cocoa flavanols and healthy blood flow. The company says its cocoa health claim is the first such claim in the world.
On September 3, the European Commission approved the following health claim for cocoa flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow.”
Because of a proprietary processing method, Barry Callebaut can retain as much as 80% of cocoa’s natural flavanols-beneficial compounds which often degrade during high-heat processing of cocoa and chocolate. The processing method is used in the company’s ACTICOA line of cocoa flavanol ingredients, and it was integral to achieving the European health claim. Cocoa flavanols have shown blood flow support in numerous studies, and with numerous suppliers’ flavanols, but the health claim is restricted to Barry Callebaut ingredients for a period of five years.
The cocoa health claim is available for servings of 200 mg of cocoa flavanols, a dose that is achievable with 2.5 g of ACTICOA powder or 10 g of ACTICOA dark chocolate. For now, the claim is restricted to beverages (made with cocoa powder) and dark chocolate.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
